117 related articles for article (PubMed ID: 3550300)
1. Autologous bone marrow transplantation in acute myeloid leukemia after in-vitro purging with an anti-lacto-N-fucopentaose III antibody and rabbit complement.
Ferrero D; De Fabritiis P; Amadori S; De Felice L; Gallo E; Meloni G; Pregno P; Pulsoni A; Simone F; Tarella C
Leuk Res; 1987; 11(3):265-72. PubMed ID: 3550300
[TBL] [Abstract][Full Text] [Related]
2. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody purging and autologous bone marrow transplantation in acute myelogenous leukemia in complete remission.
De Fabritiis P; Ferrero D; Sandrelli A; Tarella C; Meloni G; Pulsoni A; Pregno P; Badoni R; De Felice L; Gallo E
Bone Marrow Transplant; 1989 Nov; 4(6):669-74. PubMed ID: 2819285
[TBL] [Abstract][Full Text] [Related]
4. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid cell-specific monoclonal antibodies.
Ball ED; Mills LE; Coughlin CT; Beck JR; Cornwell GG
Blood; 1986 Dec; 68(6):1311-5. PubMed ID: 3535927
[TBL] [Abstract][Full Text] [Related]
5. Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrow.
Ericson SG; Colby E; Welch L; Ball ED
Bone Marrow Transplant; 1992 Feb; 9(2):129-37. PubMed ID: 1373982
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to carbohydrate antigens in autologous bone marrow transplantation.
Ball ED; Howell AL
J Cell Biochem; 1988 Apr; 36(4):445-52. PubMed ID: 3288649
[TBL] [Abstract][Full Text] [Related]
7. Bone-marrow purging with monoclonal antibodies and human complement in ALL and AML.
Majdic O; Sugita K; Touw I; Köller U; Stockinger H; Delwel R; Löwenberg B; Knapp W
Haematol Blood Transfus; 1987; 31():86-8. PubMed ID: 3327791
[No Abstract] [Full Text] [Related]
8. Autologous bone-marrow transplantation for Burkitt's lymphoma: marrow purging with anti-Y 29/55 monoclonal antibody and complement.
Baumgartner C; Delaleu B; Imbach P; Lüthy A; Odavic R; Brun del Re G; Bucher U; Forster HK; Hirt A; Wagner HP
IARC Sci Publ; 1985; (60):435-40. PubMed ID: 3905594
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow.
Almici C; Manoni L; Carlo-Stella C; Garau D; Cottafavi L; Rizzoli V
Bone Marrow Transplant; 1995 Jul; 16(1):95-101. PubMed ID: 7581136
[TBL] [Abstract][Full Text] [Related]
10. [Application of IHW2 purged bone marrow to autologous bone marrow transplantation in the treatment of acute myeloid leukemia].
Jiang R; Han M; Zhao Y
Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):312-4. PubMed ID: 11243113
[TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow transplantation for acute myeloid leukemia following in vitro treatment with neuraminidase and monoclonal antibodies.
Ball ED; Vredenburgh JJ; Mills LE; Cornwell GG; Schwarz L; Howell AL; Troy K
Bone Marrow Transplant; 1990 Oct; 6(4):277-80. PubMed ID: 1982228
[TBL] [Abstract][Full Text] [Related]
12. The combination of melphalan, cyclophosphamide and cytosine arabinoside as a conditioning regimen for autologous bone marrow transplantation for acute leukemia.
Wang C; Qiao Z; Yang L; Ma L; Zhang H; Zhang J
Chin Med J (Engl); 1996 Apr; 109(4):304-7. PubMed ID: 8758293
[TBL] [Abstract][Full Text] [Related]
13. Autologous bone marrow transplantation in acute lymphoblastic leukemia--preclinical immunologic studies.
Janossy G; Campana D; Burnett A; Coustan-Smith E; Timms A; Bekassy AN; Hann I; Alcorn MJ; Totterman T; Simonsson B
Leukemia; 1988 Aug; 2(8):485-95. PubMed ID: 3045431
[TBL] [Abstract][Full Text] [Related]
14. In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission.
Stein AS; O'Donnell MR; Chai A; Schmidt GM; Nademanee A; Parker PM; Smith EP; Snyder DS; Molina A; Stepan DE; Spielberger R; Somlo G; Margolin KA; Vora N; Lipsett J; Lee J; Niland J; Forman SJ
J Clin Oncol; 1996 Aug; 14(8):2206-16. PubMed ID: 8708709
[TBL] [Abstract][Full Text] [Related]
15. My-1, the human myeloid-specific antigen detected by mouse monoclonal antibodies, is a sugar sequence found in lacto-N-fucopentaose III.
Huang LC; Civin CI; Magnani JL; Shaper JH; Ginsburg V
Blood; 1983 May; 61(5):1020-3. PubMed ID: 6187397
[No Abstract] [Full Text] [Related]
16. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
Freedman AS; Neuberg D; Gribben JG; Mauch P; Soiffer RJ; Fisher DC; Anderson KC; Andersen N; Schlossman R; Kroon M; Ritz J; Aster J; Nadler LM
J Clin Oncol; 1998 Jan; 16(1):13-8. PubMed ID: 9440717
[TBL] [Abstract][Full Text] [Related]
17. Reactivity profiles of leukemic myeloblasts with monoclonal antibodies directed to sialosyl-Le(x) and other lacto-series type 2 chain antigens:absence of reactivity with normal hematopoietic progenitor cells.
Muroi K; Suda T; Nojiri H; Ema H; Amemiya Y; Miura Y; Nakauchi H; Singhal A; Hakomori S
Blood; 1992 Feb; 79(3):713-9. PubMed ID: 1370643
[TBL] [Abstract][Full Text] [Related]
18. In vitro purging of bone marrow for autologous marrow transplantation in acute myelogenous leukemia using myeloid-specific monoclonal antibodies.
Ball ED
Bone Marrow Transplant; 1988 Sep; 3(5):387-92. PubMed ID: 3056546
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of bone marrow purging in AML using monoclonal antibodies and complement.
Mills LE; Ball ED; Howell AL; Cornwell GG; Thompson L; Spruce W; Miller WE; McMillan R
Prog Clin Biol Res; 1990; 333():165-70. PubMed ID: 2308980
[No Abstract] [Full Text] [Related]
20. Transplantation of monoclonal antibody-purged autologous bone marrow for treatment of poor risk common acute lymphoblastic leukemia.
Bradstock KF; Stevens M; Bergin M; Dalla-Pozza L; Duval P; Favaloro EJ; Kabral A; Kerr A; Juttner C; Zola H
Aust N Z J Med; 1987 Jun; 17(3):283-9. PubMed ID: 2960307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
